Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Latest News

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

globenewswire.com
ELTX

SkyAI Comments on Annual Meeting Results

globenewswire.com
SKYA

Diginex Consolidates Group-Wide Expertise and Launches Sustainability Science & Intelligence Initiative to Accelerate Product Innovation and Drive Measurable Client Outcomes

globenewswire.com
DGNX

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

globenewswire.com
MIST

Synack Expands Access to AI and Human Penetration Testing Across Cloud and Public Sector Marketplaces

globenewswire.com
MSFT AMZN GOOGL

Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis

globenewswire.com
ABSI

EBANX advances emerging market infrastructure with Pakistan expansion in motion and native Apple Pay decryption

globenewswire.com
AAPL

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

globenewswire.com
LSTA

Cadillac Mines Appoints Pierre Beaudoin to Board of Directors

globenewswire.com
CSTL AGNC GFI

SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma

globenewswire.com
SLBT